Radiotheranostics Market 2030: Rising Prevalence of Cancer Driving Market Growth
Global Radiotheranostics Market Overview The global radiotheranostics market was valued at USD 7.51 billion in 2022 and is projected to reach USD 20.69 billion by 2030, growing at a CAGR of 13.49% from 2023 to 2030. The expanding use of nuclear medicine in managing a wide range of chronic diseases, along with the rising adoption of precision medicine, is expected to drive market growth. Additionally, the growing demand for radiotheranostics that exhibit biological activity to target specific disorders and monitor treatment outcomes is positively influencing the market. However, factors such as the short half-life of radioisotopes and high treatment costs may hinder growth to some extent. The rising incidence of cancer is a major factor fueling demand for radiotheranostics. According to the American Cancer Society, the U.S. reported 1.9 million new cancer cases and 609,360 deaths. This increasing cancer burden has intensified the need for nuclear medicine, which plays a vital role i...